Lil­ian heads up Stern IR, which pro­vides dif­fer­en­ti­at­ed investor and com­mu­ni­ca­tions con­sult­ing to the biotech­nol­o­gy indus­try. She holds an A.B. from Cor­nell Uni­ver­si­ty in mol­e­c­u­lar biol­o­gy and bio­chem­istry as well as a J.D. from Har­vard Law School. In addi­tion to the JBC, she serves on the board of trustees of the Leukemia and Lym­phoma Soci­ety and the JCC of Man­hat­tan.